Infectious Diseases (all articles)
Germans embrace fresh air to ward off coronavirus
2 Oct, 2020 | 09:18h | UTCGermans embrace fresh air to ward off coronavirus – The Guardian
Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers
1 Oct, 2020 | 09:17h | UTCCommentary: Hydroxychloroquine didn’t prevent COVID-19 among health care workers in new study – CNN
Commentary on Twitter
#Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infection, in a double-blind randomized placebo-controlled trial performed at 2 University of Pennsylvania hospitals https://t.co/7XHn6uBh4Z
— JAMA Internal Medicine (@JAMAInternalMed) September 30, 2020
This overlooked variable is the key to the pandemic. It’s k, the dispersion factor, not R.
1 Oct, 2020 | 09:12h | UTCThis Overlooked Variable Is the Key to the Pandemic. It’s not R. – The Atlantic
Commentary on Twitter
It's k, the dispersion factor, not R. @zeynep's ★ synthesis of the opportunity to get ahead of the virus by taking advantage of the 80/20 rule for how it spreads, the avoidance of superspreading (not overlooked by me; a compelling case here)https://t.co/dZSHHdkOTA @TheAtlantic
— Eric Topol (@EricTopol) September 30, 2020
COVID has killed more than one million people. How many more will die?
1 Oct, 2020 | 09:13h | UTCCOVID has killed more than one million people. How many more will die? – Nature
Commentary on Twitter
Researchers warn that official figures underestimate the pandemic’s real death toll, which could more than triple if the virus is allowed to spread unchecked. https://t.co/H9hbI38ZEa
— Nature News & Comment (@NatureNews) September 30, 2020
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline
1 Oct, 2020 | 09:15h | UTC
Commentary on Twitter
?Just published?@CMIJournal
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline by the Dutch Working Party on Antibiotic Policy. #IDTwitter #COVID19 https://t.co/7cfZtS6Duv pic.twitter.com/Kz7CPMNLmh— Antibiotic Steward? Bassam Ghanem (@ABsteward) September 30, 2020
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps
1 Oct, 2020 | 09:09h | UTC
Commentary on Twitter
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gapshttps://t.co/vPWuNytBPP pic.twitter.com/pbLY1m9ZD2
— BMJ Global Health (@GlobalHealthBMJ) September 30, 2020
Audio interview: Covid-19 testing and the individual physician
1 Oct, 2020 | 09:11h | UTCAudio Interview: Covid-19 Testing and the Individual Physician – New England Journal of Medicine
Perspective: Rethinking Covid-19 test sensitivity — a strategy for containment
1 Oct, 2020 | 09:10h | UTCRethinking Covid-19 Test Sensitivity — A Strategy for Containment – New England Journal of Medicine
A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates
1 Oct, 2020 | 09:04h | UTC
Commentary on Twitter
(1/3) Excellent, rigorous review and meta-analysis of #COVID19 infection fatality ratio (IFR).
The overall IFR was 0.68% (95% CI 0.53-0.82%).
If only studies with a low risk of bias were included, the IFR rose to 0.76% (0.37-1.15%).https://t.co/F5GN0253lz https://t.co/7ucGgQ78AM pic.twitter.com/laHO3e4sl3
— Dr Zoë Hyde (@DrZoeHyde) September 30, 2020
Viewpoint: COVID-19 and heart failure with preserved ejection fraction
1 Oct, 2020 | 09:06h | UTCCOVID-19 and Heart Failure With Preserved Ejection Fraction – JAMA
Invasive candidiasis in critical care: Challenges and future directions
1 Oct, 2020 | 09:00h | UTCInvasive candidiasis in critical care: challenges and future directions – Intensive Care Medicine
Commentary on Twitter
Invasive candidiasis: most common #ICU fungal infection ~40-55% mortality. Key challenges:
➡️ changing epidemiology/emergence of resistances
➡️ timely/appropriate therapy initiation/discontinuation
➡️ choosing/tailoring optimal antifungals#FOAMcc review https://t.co/tMPNcYfzwL pic.twitter.com/HvJKr0jX2o— Intens Care Med (@yourICM) September 30, 2020
New COVID-19 inpatient risk calculator estimates the probability of severe disease or death at hospital admission
30 Sep, 2020 | 09:51h | UTCCommentaries: COVID-19 ‘prediction model’ uses data that can help determine if patients’ conditions are likely to worsen – Johns Hopkins Medicine AND Prediction model incorporates more than 20 variables at hospital admission – Physician’s Weekly AND Patient Trajectories Among COVID-19 Hospitalized Patients – American College of Cardiology
Interactive Calculator: The COVID Inpatient Risk Calculator: CIRC
Commentary on Twitter
Lead authors Brian T. Garibaldi, MD, MEHP and Jacob Fiksel, PhD of @HopkinsMedicine developed the COVID-19 Inpatient Risk Calculator (CIRC) that uses patient data at admission to determine potential disease trajectory for #COVID19.
Link: https://t.co/i1e1ek7wO7. @Bedsidemedicine pic.twitter.com/wQLctHHYrn
— Annals of Int Med (@AnnalsofIM) September 22, 2020
[Abstract Only] Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer
1 Oct, 2020 | 08:56h | UTCHPV Vaccination and the Risk of Invasive Cervical Cancer – New England Journal of Medicine
News Release: HPV vaccine effective against cervical cancer – Karolinska Institutet
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions
30 Sep, 2020 | 09:48h | UTC
Commentary on Twitter
A reassuring note about lack of virus being cultured from surfaces, fomites, even in the hospital setting, pointing against this mode of transmission https://t.co/iMhzB6nvqQ @TheLancetInfDis pic.twitter.com/zJDuhc3BBC
— Eric Topol (@EricTopol) September 29, 2020
Proposed clinical criteria for COVID-19-associated hyperinflammatory syndrome
30 Sep, 2020 | 09:50h | UTC
Commentary on Twitter
Defining and grading the clinical hyperinflammatory syndrome with #COVID19 and how this cytokine storm relates to outcomes https://t.co/6Ngp3OHZJx @TheLancetRheum @Intermountain pic.twitter.com/bDGwKpjOI4
— Eric Topol (@EricTopol) September 29, 2020
Recent increase in COVID-19 cases reported among adults aged 18–22 years in the US
30 Sep, 2020 | 09:44h | UTCCommentary: CDC Documents Increase in Coronavirus Cases Among Young Adults – U.S.News
Commentary on Twitter
New @CDCMMWR shows #COVID19 infections among 18-22 year-olds increased more than 50% from early August to early Sept. Everyone needs to help slow the spread of COVID-19. Wear a mask, stay 6 feet from others, wash hands often, & stay home when sick. https://t.co/OLCkD1v23I pic.twitter.com/hu7R5QFlpb
— CDC (@CDCgov) September 29, 2020
Preventing and responding to COVID-19 on college campuses
30 Sep, 2020 | 09:47h | UTCPreventing and Responding to COVID-19 on College Campuses – JAMA
Multiple COVID-19 clusters on a university campus
30 Sep, 2020 | 09:46h | UTCCommentary: Student gatherings, congregate living contribute to rapid coronavirus spread at universities: CDC – The Hill
Commentary on Twitter
A new @CDCMMWR details rapid spread of #COVID19 at a university shortly after opening. Many of the cases were linked to residence halls, fraternities/sororities, off-campus apartments, & athletic teams. Learn more: https://t.co/TVDq49frkF. pic.twitter.com/MBz6HMH3Qg
— CDC (@CDCgov) September 29, 2020
CDC study shows a substantial increase in COVID-19 rates among school-aged children in the US
30 Sep, 2020 | 09:43h | UTCCommentaries: Coronavirus Rates For Teens Are Nearly Double Rate For Children, CDC Finds – Forbes AND Research shows substantial increase in COVID-19 rates in children, especially adolescents – ABC News
Commentary on Twitter
(1/7) Study of #COVID19 in US children. 277,285 cases were reported between 1 March and 19 September. Incidence higher in adolescents compared to young children (although more adolescents were tested). 1.2% were hospitalised (0.1% ICU), and 0.02% died.https://t.co/NjNFBRRyYg pic.twitter.com/83G6Y6oqyF
— Dr Zoë Hyde (@DrZoeHyde) September 29, 2020
Intensive care unit acquired muscle weakness in COVID-19 patients
30 Sep, 2020 | 09:39h | UTCIntensive care unit acquired muscle weakness in COVID-19 patients – Intensive Care Medicine
Commentary on Twitter
#ICU acquired muscle weakness in #COVID19 frequently occurring in critically ills on prolonged sedation. Price to pay for rigorous protective MV? follow-up essential to offer tailored rehab, trying to reduce long-term impact on functional status. #ICUrehab https://t.co/anf0WE0W4w pic.twitter.com/MdnNzYuTN8
— Intens Care Med (@yourICM) September 28, 2020
When young people get COVID-19, infections soon rise among older adults
30 Sep, 2020 | 09:41h | UTCWhen Young People Get COVID-19, Infections Soon Rise Among Older Adults – NPR
“rising infections among young adults preceded increases in COVID-19 — by four to 15 days — among people over the age of 60.”
Commentary on Twitter
A recent CDC report confirms what many public health experts have been warning: Coronavirus cases in young adults lead to infections in older and more vulnerable people — who are more likely to be hospitalized and die from COVID-19.https://t.co/r89dOJrTWj
— NPR (@NPR) September 29, 2020
Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults
30 Sep, 2020 | 09:36h | UTCOriginal Article: Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults – New England Journal of Medicine
Commentary on Twitter
The Moderna mRNA vaccine, which elicited antibodies and T cells specific for the Covid-19 virus in adults 55 years of age or younger, elicited similarly high levels of neutralizing-antibody and CD4 T-cell responses in older adults. #COVID19 #SARSCoV2
— NEJM (@NEJM) September 29, 2020
What people get wrong about herd immunity, explained by epidemiologists
30 Sep, 2020 | 09:38h | UTCWhat people get wrong about herd immunity, explained by epidemiologists – Vox
Less than 10% of US population has COVID-19 antibodies, data show
29 Sep, 2020 | 10:12h | UTCLess than 10% of US population has COVID-19 antibodies, data show – CIDRAP
Original Study: Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study – The Lancet
Commentary on Twitter
NEW Research—Nationwide cross-sectional analysis of US patients receiving dialysis finds fewer than 10% of people had #COVID19 antibodies by July 2020, and fewer than 10% of those with antibodies had been diagnosed by antigen or PCR testing https://t.co/QWPMO0gCr3 pic.twitter.com/v2K66uLLID
— The Lancet (@TheLancet) September 26, 2020
Mass screening of asymptomatic persons for SARS-CoV-2 using saliva
29 Sep, 2020 | 10:13h | UTCMass screening of asymptomatic persons for SARS-CoV-2 using saliva – Clinical Infectious Diseases
Commentary: COVID-19: Saliva tests could detect silent carriers – Hokkaido University